TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: grade 3-4 nivolumab toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Degree of pathologic response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinically successful pulpotomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: radiographically successful pulpotomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Extent of DNA damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity and prognosis of nonischemic cardiomyopathic patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of cardiac function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of symptomatic hypoglycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: User feedback on Ambulatory Monitoring Solution
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Area under the concentration time curve (AUC(0-T))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effective use of ICU
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Number of participants who achieve Objective Response (OR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scar thickness at postpartum 6th week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scar thickness at postpartum 6th month
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Data completion on PANSS interview
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specific microbial genus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of care for burn children
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Urine Specific Gravity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The Liverpool Jet Lag questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Lake Louise Acute Mountain Sickness Assessment System
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Neuropsychological tests (Trail Making Test, Wechsler Memory Scale - IV, Free recall)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Delay to achieve train of four ratio > 0.9
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delay to achieve tetanus 100 Hz ratio > 0.9
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiation-induced cancer risk
Endpoint domain: Mortality/survival
Primary endpoint: occurrence of pancreas-specific complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of Participants With Hepatotoxicity Treatment-emergent Adverse Events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Grade 3 to 5 AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Left atrium reservoir strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Adverse Events Reporting
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients experiencing adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of translational treatment adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: MPR (Major Pathological Response)
Endpoint domain: Physiological/clinical
Primary endpoint: pCR (Pathological Complete Response)
Endpoint domain: Physiological/clinical
Primary endpoint: Effect on Threat Reactivity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Concordance between AI tool and reference standard
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of Atrial Fibrillation or Flutter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Ratio of GMT of SARS-CoV-2 B.1.1.529 neutralizing antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Difference in seroresponse rate (SRR) of SARS-CoV-2 B.1.1.529 neutralizing antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Assessment of major depressive episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immune activating response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serum Brain-derived neurotrophic factor (BDNF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Functional near-infrared spectroscopy (fNIRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of asthma exacerbation detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Accuracy of COPD exacerbation detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Oxygen Index (OI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Average Sweat Rate Per Hour per patient
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of device- and procedure-related side-effects
Endpoint domain: Adverse events/effects
Primary endpoint: 6 min walking test (6MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transcutaneous carbon dioxide measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time between date of arrival in France and breast cancer diagnosis
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Time between breast cancer diagnosis and access to care
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in posttraumatic stress disorder symptom severity - clinician rated
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in metabolic control: tyrosine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in metabolic control: phenylalanine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in FEOVB uptake through PET Imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in triglycerides from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Body fat distribution and muscle content from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in vitamin A status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in vitamin E status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in B-vitamin static indicators
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in B-vitamin enzymatic activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Plasma IL-6 (Interleukin 6, pg/mL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Plasma CRP (C-Reactive Protein, ng/mL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Plasma D-Dimer, pg/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with improved swallowing (PAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with improved swallowing (FOIS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with perceived improvements in swallowing
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number diagnosed with pre-eclampsia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Validation of POSSUM and P-POSSUM systems
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: NK cell phenotype
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change from baseline COPD-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Metabolic disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Chronic disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tumor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Time-weighted average intraoperative mean arterial pressure under 65 mmHg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Feasibility of augmented reality
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Quality of Care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Seizure Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in participants' systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in participants' Hemoglobin A1c
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in participants' total cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mpox serology
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Rate of highly satisfied Patients
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Temperature of follicular phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Temperature of luteal phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Days of follicular phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Days of luteal phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Transpulmonary Driving Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mean scores of Cervical Cancer and Pap Smear Test Health Belief Model Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Overall Health-Related Quality of Life (HRQOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Percentage of functional impairments
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: success rate of anastomosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Throat Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absence of Clinical Spasms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Resolution of Hypsarrhythmia or Significant Abnormality Compatible with Infantile Spasms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Knowledge level of the sample group
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Skill levels of the sample group
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: PPIX tissue fluorescence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Change From Baseline in Urinary Albumin to Creatinine Ratio (UACR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: pHRM pressure change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Swallowing clinical and fluoroscopic change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Patient reported outcome changes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pain during insertion of the catheter
Endpoint domain: Adverse events/effects
Primary endpoint: Color difference (Delta E)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: degree of implementation of the PBM programme
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Time from tube feeding to oral intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy by response to treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prescription level of guideline-directed medical therapy for HF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Target dose of guideline-directed medical therapy for HF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Curve from Time 0 to the Last Measurable Concentration (AUC0-t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in Disease Activity Score of 28 Joints Using C-reactive Protein (DAS28-CRP) at Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacokinetic Parameters AUC for Midazolam
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacokinetic Parameters CMAX for Midazolam
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric Mean Ratios for Midazolam
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delta Compliance (T1 - T7)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delta Compliance (T1 - T8)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delta Compliance (T7 - T8)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tooth Structure Development Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bony Crypt Growth Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CRS-R total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity and specificity of AutoCathFFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of germline alterations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dyspnea-MDP scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Reliance upon coping mechanisms such as drugs or alcohol
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Sum of pain intensity differences at 55 min
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: extubation failures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Rate pressure product (HR*SBP/100)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Heart rate in beats per minute
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Respiratory rate in breaths per minute
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: SpO2 in percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: End-tidal CO2 in mmHg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Oxygen flow levels in Liters per minute
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Clinical Symptoms - Positive and Negative Syndrome Scale (PANSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognition - Matrics Consensus Cognitive Battery (MCCB)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Function - Functional Capacity: UCSD Performance-Based Skills Assessment, Brief Version (UPSA-B)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Function - Psychosocial Recovery: World Health Organization Disability Schedule 2.0 (WHODAS)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Number of participants who remain in the study 3 months after baseline assessment
Endpoint domain: Mortality/survival
Primary endpoint: Number of participants with intervention-related adverse events as assessed by CTCAE v4.0
Endpoint domain: Adverse events/effects
Primary endpoint: Motor Evaluation Scale For Upper Extremity In Stroke Patients (MESUPES)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Score on the Body Feelings and Illusions questionnaire (BoFI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Wolf motor function test (WMF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The motor activity log
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: The Ashworth scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participant satisfaction rating
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change of TCSS scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change of nerve conduction velocities in the lower extremity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Time to waitlisting for liver transplant
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Depressive levels of caregivers
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Emotional functioning/wellbeing
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Moderate-to-severe adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Timing to return of bowel function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Anterior scleral thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Posterior scleral thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Identification of use errors and close calls
Endpoint domain: Adverse events/effects
Primary endpoint: Use difficulties associated with hazard-related scenarios
Endpoint domain: Adverse events/effects
Primary endpoint: Effectiveness of key information for safety
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Aggression and Delinquency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants with Out of Home Placement
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in Recidivism Risk
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Surgical complications Clavien-Dindo >grade 2
Endpoint domain: Adverse events/effects
Primary endpoint: Usability of the telerehabilitation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feasibility of the telerehabilitation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Acceptance of the telerehabilitation
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Safety and tolerability of RN0191
Endpoint domain: Adverse events/effects
Primary endpoint: Amount of prescribed antibiotics
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Correct antibiotic treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to treatment recommendations
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in sustained attention assessed with the Psychomotor Vigilance Task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in mean reaction time assessed with the Psychomotor Vigilance Task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the level of subjective sleepiness assessed with the Karolinska Sleepiness Scale
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Changes in sleep continuity
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Number of Participants with Treatment-Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants with Clinical Abnormal Changes in Coagulations Markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: pCR rate after neoadjuvant treatment
Endpoint domain: Mortality/survival
Primary endpoint: Mini-Balance Evaluation Systems Test (mini-BESTest)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 10-meter Walk Test (10MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Validate Blood Biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Identify Blood/Lipid Profiles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Metabolites Correlating with Cognitive Decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Correlation with actual birth weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Incidence of postembolism syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes